|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/138 | |||
| A61P 25/28 |
| (11) | Patento numeris | 1458368 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02789574.7 |
| Europos patento paraiškos padavimo data | 2002-11-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-09-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2002/036132 |
| Data | 2002-11-27 |
| (87) | Numeris | WO 2003/049724 |
| Data | 2003-06-19 |
| (30) | Numeris | Data | Šalis |
| 339174 P | 2001-12-11 | US |
| (72) |
BYMASTER, Franklin, Porter, US
GEHLERT, Donald, Richard, US
MCKINZIE, David, Lee, US
YANG, Charles, Renkin, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE |
| USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE |